{
    "medicine_id": "5743f032c33a8fb3775b2895886d2e45c71ea456",
    "platform_id": "DB09151",
    "metadata": {
        "name": "Vizamyl 4 05 mCi 1mL Solution",
        "composition": "4 05 mCi 1mL Flutemetamol 18F",
        "clinical_particulars": {
            "therapeutic_indications": "Flutemetamol F18 is indicated for Positron Emission Tomography PET imaging of the brain to estimate \u03b2 amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer s disease AD or other causes of cognitive decline",
            "contraindications": {
                "disease": "Most commonly reported adverse reactions were flushing 2 headache 1 increased blood pressure 2 nausea 1 and dizziness 1",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Following intravenous injection flutemetamol F 18 diffuses across the human blood brain barrier and produces a radioactivity signal detectable throughout the brain Subsequently cerebral perfusion decreases the brain flutemetamol F 18 content with differential retention of the drug in cortical areas that contain \u03b2 amyloid aggregates compared to areas that lack the aggregates",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}